Dr Steve Lee takes charge as CEO of Eden Biologics

Taiwan-based Eden Biologics, Inc. has announced the appointment of Dr Steve Lee, an accomplished biotech executive with broad experience and entrepreneurial leadership, as the new Chief Executive Officer (CEO) and Director of the Board. Dr Lee is a global business leader with a distinguished track record in biologics research, bioprocess development, technical operations, business development, strategic planning, and commercial manufacturing in a highly regulated environment and emerging markets for over 30 years. Specifically,

Dr Lee has led changes in transforming companies into high-performance organisations in biotech startups and large biopharmaceutical groups in the United States and Asia. Previously the CEO and Founder of BioGENEXUS, Dr Lee developed disruptive innovation and breakthrough manufacturing technology platforms while providing biotech consulting services globally. Now he brings his extensive biotech industry experience, strong leadership and passion to Eden Biologics with hopes of expanding Eden’s innovative, cost-effective biologics development platform and commercial manufacturing alliances in both Asia and the US.